Aim: Peripheral artery disease (PAD) is a vascular disease affecting peripheral circulation. Recently, genome-wide association studies revealed a relationship between single nucleotide polymorphisms (SNPs) in ADAMTS7 (a disintegrin and metalloprotease with thrombospondin motif 7) and atherosclerosis. In this study, we aimed to determine ADAMTS7 expression in peripheral blood mononuclear cells (PBMCs) and the frequency of ADAMTS7 rs1994016 and rs3825807 polymorphisms in a sample of Turkish patients with PAD, and to evaluate the association of matrix metalloproteinase (MMP) levels with PAD development.
brachial index (ABI).
2 Both genetic and environmental risk factors play important roles in PAD development. Hypertension, hyperlipidemia, diabetes mellitus, abnormal homocysteine levels, obesity, cigarette smoking, and familial predisposition are some of the risk factors. PAD development may also be independently influenced by genetic factors.
Recently, genome-wide association studies (GWAS) identified single nucleotide polymorphisms (SNPs) in ADAMTS7 (a disintegrin and metalloprotease with thrombospondin motif 7), and these SNPs were associated with coronary artery disease (CAD) in several populations. [3] [4] [5] [6] ADAMTS7 belongs to the ADAMTS family of disintegrins and metalloproteases with thrombospondin type-1 repeats, and it contains a signal peptide, a prodomain, a disintegrin-like domain, and a thrombospondin type-1 motif. The prodomain is cleaved during ADAMTS7 maturation and activation. 7 Activated ADAMTS7 has proteolytic activity, and its best-known substrate is thrombospondin-5 (TSP 5; also known as COMP), which is an extracellular matrix (ECM) protein found in vascular walls and cartilage. 8, 9 Studies have shown that ADAMTS7
is involved in the degradation of TSP 5, which initiates vascular smooth muscle cell (VSMC) migration following vascular injury.
9
Various proteinases are produced in atherosclerosis. Inflammatory macrophages and foam cells trigger the destruction of structural ECM components, especially collagens, and overstimulation of resident
VSMCs and endothelial cells that provide tensile strength. 10 A study demonstrated that siRNA-mediated inhibition of ADAMTS7 reduced the proteolysis of TSP 5 and impaired VSMC migration in culture and intima formation in a rat carotid balloon injury model.
Atherosclerosis is an inflammatory process involving matrix metalloproteinase (MMP) activation. MMPs degrade collagen and allow SMC migration within a vessel, which also leads to the accumulation of cellular materials, resulting in vessel occlusion and ischemia. 10 It was previously reported that activation of the MMP-8/ADAM-10 cascade increased the proliferation and migration of mouse VSMCs and promoted neointima formation.
11
Polymorphisms and mRNA expression of the ADAMTS7 gene and related MMP levels may have a phenotypic and clinical significance in PAD development. Exploring the possible relationship between the ADAMTS7 gene and PAD may contribute to elucidation of the molecular pathogenesis of PAD and may be useful in future treatment strategies. To date, the association of ADAMTS7 mRNA and protein levels and the rs1994016 and rs3825807 (Ser214Pro) polymorphisms with PAD and with plasma MMP levels has not been reported. Thus, we tested the hypothesis that ADAMTS7 levels and the rs1994016
and rs3825807 variants play a role in PAD development and investigated whether ADAMTS7 mRNA and protein levels, rs1994016 and rs3825807 polymorphisms, and plasma MMP levels are associated with PAD and its clinical parameters. as assessed from patients' responses to a health questionnaire.
| MATERIALS AND METHODS

| Subjects
| Blood samples and DNA isolation
Venous blood samples from all participants were collected into EDTA tubes for DNA isolation and stored in aliquots at −20°C until use.
Genomic DNA was extracted from whole blood using a commercial kit (Roche Diagnostics GmbH, Mannheim, Germany) according to the manufacturer's instructions.
| Blood sampling, peripheral blood mononuclear cell (PBMC) isolation, and RNA isolation
Venous blood samples obtained from all participants were collected into heparin tubes and immediately used for lymphocyte separation and RNA extraction. PBMCs were isolated from 10 mL of sodium heparin-treated venous blood samples by Ficoll-Hypaque gradient centrifugation. Total RNA was extracted from freshly isolated PBMCs by using the PureLink RNA Mini Kit (Life Technologies, Carlsbad, CA, USA) according to the manufacturer's instructions.
| Reverse transcription quantitative real-time PCR (RT-qPCR)
Total RNA (400 ng) was reverse transcribed using random hexamers as primers and reverse transcriptase, with a total volume of 20 μL.
ADAMTS7 expression in PBMCs was determined by quantitative real-time polymerase chain reaction (RT-qPCR) by using a LightCycler 1.5 system (Roche Applied Biosystems, CA, USA) with UPL probes and the TaqMan method. ADAMTS7 mRNA levels were normalized to ACTB, B2M, and GAPDH mRNA levels, which were used as endogenous reference genes. The following primer sequences were used: 
| Genotyping of rs1994016 and rs3825807 SNPs in the ADAMTS7 gene
The rs1994016 and rs3825807 SNPs in ADAMTS7 were deter- A standard curve was constructed using a 5-parameter logistic (5PL) regression, and the concentration of each MMP (pg/mL) was calculated against this curve.
| Multiplex immunoassay
| Western blot analysis
Peripheral blood mononuclear cell extracts were collected and the total protein was isolated using a Total Protein Extraction Kit (Chemicon International, Billerica, MA, USA). Total proteins were separated by SDS gel electrophoresis and transferred onto PVDF membranes, which were incubated with rabbit anti-human ADAMTS7 polyclonal antibody
(1:3000 dilution; Abcam, Cambridge, MA, USA), rabbit anti-human ACTB polyclonal antibody (1:5000 dilution; Abcam), and goat anti-rabbit IgG peroxidase-conjugated H+L antibody (1:5000 dilution; Abcam). Specific bands were detected using a Bio-Rad imaging system (Bio-Rad). Relative protein expression change was determined using Image J software (free software from National Institutes of Health, Bethesda, MD, USA). 
| Statistical analysis
| RESULTS
| Patient demographics
There were no statistically significant differences between the groups with respect to age (P=.39) or gender (P=.33). However, PAD patients and controls demonstrated significant differences in hematocrit, fasting glucose, urea, creatinine, serum CRP levels (P<.001), and systolic blood pressure (P=.01), but not in AST, ALT, total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride, or diastolic blood pressure levels (P>.05; Table 1 ).
| ADAMTS7 mRNA and protein levels
ADAMTS7 mRNA levels were significantly increased in PAD patients compared to healthy controls (t=−2.75, P=.007; Figure 1 ). ADAMTS7
protein levels were also demonstrated to be higher in PAD patients than in controls (Figure 2 ).
| Genotype frequencies of ADAMTS7 rs1994016 and rs3825807 SNPs
The genotype distributions for the rs1994016 and rs3825807 SNPs in PAD patients and controls are presented in No significant difference was observed in the genotype frequencies of the ADAMTS7 rs1994016 SNP between PAD patients and controls (P=.185). However, the rs1994016 T allele frequency was higher in PAD patients than in controls, although the difference was not significant (P=.06). There was also no significant difference between genotypic frequencies for the rs3825807 SNP (P=.177; Table 2 ).
| ADAMTS7 gene expression with regard to rs1994016 and rs3825807 genotypes
ADAMTS7 mRNA levels were significantly increased for the CC genotype of SNP rs1994016 (t=−2.31, P=.026), and the TT genotype of SNP rs3825807 in PAD patients (t=−2.23, P=.032; Figure 3 ).
| Plasma MMP levels
Plasma MMP-1, MMP-3, MMP-7, MMP-10, MMP-12, and MMP-13 levels were significantly higher in PAD patients than in controls (P<.05; Figure 4 ). 
| Correlation of ADAMTS7 gene expression with triglyceride and LDL and HDL cholesterol levels
| ADAMTS7 gene expression and ADAMTS7 rs1994016 and rs3825807 SNPs with regard to PAD risk factors
We analyzed the potential selective effects of ADAMTS7 mRNA levels and ADAMTS7 rs1994016 and rs3825807 SNPs in patients by using 
| DISCUSSION
Several GWAS have revealed that SNPs in ADAMTS7 are associated with CAD. [3] [4] [5] The CAD-related SNP rs3825807 results in an amino acid substitution (Ser-to-Pro) in the ADAMTS7 prodomain. 5 The effects of two other SNPs, rs1994016 in intron 8 4 and rs4380028 at 7.6 kb upstream of the gene, 3 on ADAMTS7 expression or activity in CAD development remain unclear. However, to the best of our knowledge, the association between ADAMTS7 levels, rs1994016
and rs3825807, and plasma MMP levels in PAD pathogenesis has not been reported previously.
SiRNA-mediated inhibition of ADAMTS7 was shown to reduce the proteolysis of TSP 5 and impaired VSMC migration in culture. 9 It has also been reported that ADAMTS7 promotes VSMC proliferation both in vitro and in vivo and may therefore serve as a therapeutic target for atherosclerosis. 12 TSP 5, which is produced by VSMCs and which inhibits VSMC migration, has also been demonstrated to suppress VSMC phenotypic modulation, thereby promoting neointima formation. 13, 14 Because VSMC migration is a significant component of atherogenesis, ADAMTS7 may play a role in PAD development as well. However, the underlying mechanism is not yet understood.
In our study, PAD patients and controls demonstrated significant differences in the levels of hematocrit, fasting glucose, urea, creatinine, serum CRP, and systolic blood pressure but not in the levels of AST; ALT; total, HDL, and LDL cholesterol; diastolic blood pressure;
and triglycerides. Furthermore, ADAMTS7 mRNA levels were significantly higher in PAD patients than in healthy controls, suggesting that ADAMTS7 may play a significant role in peripheral circulation and its pathologies such as PAD.
A GWAS reported that lower susceptibility to CAD was associated with rs3825807. 5 Another GWAS found that the rs1994016 variant was associated with the incidence of symptomatic CHD but not with that of MI. 4 However, none of these studies clarified whether the SNPs have functional effects on ADAMTS7 expression or activity in CAD development. In the present study, no significant difference was F I G U R E 3 ADAMTS mRNA expression with regard to rs1994016 and rs3825807 variants observed in the genotype frequencies of rs1994016 between PAD patients and controls. However, the T allele frequency of rs1994016 was higher in PAD patients than in controls, although the difference was not significant. We also did not observe any significant difference in the genotype frequencies of rs3825807 between PAD patients and controls. This result may be due to the small sample size. However, the risk alleles rs1994016 (C allele) and rs3825807 (T allele) were found to influence PAD pathogenesis in our study. Furthermore, considering the localization of the SNPs in relation to ADAMTS7, they may influence ADAMTS7 expression.
Pu et al. 15 reported that rs3825807 had a suppressive effect on ADAMTS7 maturation, TSP 5 cleavage, and VSMC migration. They also reported that Ser-to-Pro substitution reduced ADAMTS7 prodomain processing and that the ADAMTS7 rs3825807 genotype (Pro) was associated with lower atherosclerosis prevalence and severity. An association between ADAMTS7 rs3825807 and aortic calcification has also been reported. 16 You et al. 17 reported that ADAMTS7 rs3825807 was associated with CAD susceptibility and severity in a Chinese population. Consistent with these reports, in our study, ADAMTS7 expression levels were significantly higher for the TT genotype of rs3825807 among PAD patients. In the rs3825807 Ser214Pro polymorphism, the amino acid change from serine (polar) to proline (non-polar) may influence ADAMTS7 levels because this change occurs in the prodomain of the protein. Furthermore, in our study, ADAMTS7 mRNA levels were significantly increased for the F I G U R E 4 Plasma MMP levels among PAD patients and controls F I G U R E 5 Correlation of MMP-8 and -9 levels with blood lipid parameters CC genotype of rs1994016 among PAD patients, suggesting a potential allelic effect on ADAMTS7 expression in PAD development.
Matrix metalloproteinases have been reported to exert both adverse and protective effects on plaque rupture in animal models.
18
MMPs may be involved in VSMC proliferation via indirect effects, such as release of matrix-anchored growth factors or removal of cell-cell contact proteins. 19 However, metalloproteinases other than
MMPs may contribute to enhancement of VSMC proliferation in vivo.
ADAMTS7 enhances VSMC proliferation both in vitro and in vivo.
12
Wu et al. 20 investigated plasma ADAMTS7 levels in acute myocardial infarction (AMI) and reported that ADAMTS7 levels may be associated with heart failure after AMI.
In atherosclerosis, high production of a wide range of proteinases triggers the recruitment of inflammatory macrophages and foam cells and overstimulates resident VSMCs and endothelial cells, which leads to destruction of ECM components. 10 In our study, plasma MMP-1, MMP-3, MMP-7, MMP-10, MMP-12, and MMP-13 levels were significantly higher in PAD patients than in controls. Furthermore, in PAD patients, plasma MMP-8, MMP-10, and MMP-13 levels were significantly correlated with the levels of triglycerides and total and LDL cholesterol, whereas plasma MMP-9 levels were significantly correlated with LDL cholesterol levels.
Moreover, risk factors such as serum CRP levels and ADAMTS7 expression were significantly associated with PAD development. Based on this evidence, we suggest that ADAMTS7 and various MMPs may play a role in the inflammatory mechanisms in PAD pathogenesis.
| CONCLUSION
Because PAD is a multifactorial and complex disease, its molecular pathogenesis is still unknown. Our study has some limitations; a larger sample size and analysis of serum/plasma ADAMTS7 protein levels to confirm the results would also help us to understand the disease pathogenesis. However, although our study has some limitations, it is the first study to evaluate the possible role of the ADAMTS7 gene and various MMPs in PAD development, and our findings suggest a possible relationship between MMP-related genes and atherosclerotic PAD. The results of our study suggest that the ADAMTS7 gene may be associated with PAD development in this study population and that the rs1994016 CC and rs3825807 TT genotypes may upregulate ADAMTS7 mRNA levels and may influence PAD development.
ADAMTS7 may also have clinical significance in PAD development.
Confirmation of these findings in future studies may support the use of ADAMTS7 inhibitors to reduce the severity of atherosclerosis and PAD-related symptoms.
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